NovoSeven
eptacog alfa (activated)
Hemophilia B
Thrombasthenia
Factor VII Deficiency
Hemophilia A
Date of authorisation:
Revision: 38
Last updated:
MedicineHumanAuthorised
HemAryo
eptacog alfa (activated)
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
EMEA-002943-PIP01-20 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0197/2021
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001382-PIP01-12 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Haematology-Hemostaseology
PIP number: P/0270/2013
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder and solvent for solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman